Founded in 1985, INDUNIV is a nonprofit organization representing industry, government and the academic sector. The center promotes the island’s competitiveness in science and technology. Its efforts pave the way for the knowledge economy.
INDUNIV advances understanding of the pharmaceutical and bioscience development fields; facilitates collaboration between industry, government and academia; develops strategies and road maps to formulate public policy and advocates its implementation. It is a relentless promoter and catalyst for the development of centers of excellence, technology parks and incubators to pave the way in the value chain for the innovation through commercialization of products, enhancing Puerto Rico’s competitiveness and making it more attractive for manufacturing activities.
The center is governed by a Board of Directors with representatives from industry, government and academia. INDUNIV’s work is financed by donations from industry and academia, income from the events it organizes and a matching grant from PRIDCO. Allocations for research are secured through a grant from the University of Puerto Rico.
Contact details
PRIDCO Bldg, Suite 101
PO Box 362350
San Juan, PR 00936-2350
Telephone: (787)772-4604
Fax:(787)772-9011
Basil Khalil, Vice President of Operations at FedEx, highlights the company’s expansion of healthcare logistics in Latin America, including CEIV Pharma-certified facilities, dedicated flights, and end-to-end cold-chain infrastructure. Investments in…
In cell and gene therapy, where R&D and manufacturing are inseparable, Puerto Rico’s strong biopharma base makes it an attractive option for CGT companies. The first mover in this…
Despite being a small island in the Caribbean, measuring just 100 by 35 miles, Puerto Rico has long punched above its weight as an industrial powerhouse. Already a leading producer…
Spending almost 30 years working for a single company is almost unheard of in today’s life science industry, where executives chop and change between firms with bewildering frequency. However,…
The largest pharmaceutical hub in the Americas, Puerto Rico currently exports to 120 countries, accounting for nearly USD 53 billion in weekly biopharma shipments. Remarkably, this small Caribbean island out-exports all…
Long celebrated for its world-class pharmaceutical and medical device manufacturing, Puerto Rico is now leveraging this strong foundation to nurture a new era of research and development. Rather than shifting…
Can Puerto Rico capitalise on the Trump administration’s “make in America” push? President Donald Trump wants to bring manufacturing back to America. The last 40 years of globalisation and…
With over 80,000 people directly and indirectly employed in Puerto Rico’s biosciences sector, the island relies heavily on a skilled and stable workforce to maintain its competitive edge. But it…
Across over 50 interviews with Puerto Rican government and industry stakeholders, energy supply was continuously identified as the main barrier to growth. Puerto Rico’s ageing, centralised, and fossil fuel–dependent power…
Puerto Rico’s healthcare system is a paradox of strength and fragility. With one of the highest insurance coverage rates in the US (around 94 percent) and a long tradition of…
Víctor Ramos Otero, Secretary of Health for Puerto Rico, reflects on his first 100 days in office and the key initiatives to strengthen the island’s healthcare system. He discusses efforts…
Rolando Torres, Chief Operations Officer for CooperVision, a division of global medical device company CooperCompanies, discussed the significant growth and investment CooperVision has experienced in Puerto Rico since 2019, including…
See our Cookie Privacy Policy Here
